Pharmaceutical Technology-09-02-2016

Pharmaceutical Technology

Root Cause Analysis–Finding the Root of the Problem

September 02, 2016

Ask the Expert

40

9

Siegfried Schmitt, principal consultant, PAREXEL International, discusses how to find the root cause of the problem.

Efforts Accelerate to Streamline Postapproval Change Process

September 02, 2016

Regulatory Watch

40

9

Manufacturers and regulatory authorities seek coordinated lifecycle management policies.

Liquid Handling System for Automatic Particle Characterization

September 02, 2016

Product Spotlight

40

9

The FlowCam ALH automated liquid handling system from Fluid Imaging Technologies is a particle imaging and analysis system that automatically detects, images, and characterizes individual particles and microorganisms.

Innovation vs. Capacity: How CMOs Compete

September 02, 2016

Outsourcing Outlook

40

9

The strategies of a innovation-driven CMO may be different than a capacity-driven CMO.

Commonly Cited Deficiencies for Topical Dermatologic Drug Products in ANDAs

September 02, 2016

Features

40

9

The authors of "Common Deficiencies in ANDAs for Dermatologic Drug Products" provide some examples of commonly cited deficiencies cited by FDA.

Pharmaceutical Technology, September 2016 Issue (PDF)

September 02, 2016

Issue PDF

40

9

Click the title above to open the Pharmaceutical Technology September 2016 issue in an interactive PDF format.

PDA Issues Call to Action for Faster Postapproval Changes

August 29, 2016

Regulatory Watch

40

9

The Parenteral Drug Association develops program to address barriers to implementation of postapproval changes.

When Marketing and Medicine Collide

August 24, 2016

From The Editor

40

9

Steep price increases for a popular drug have created patient and Congressional backlash.